deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT06571669

BOOM-IBD2 Pivotal Clinical Trial

BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.

Sponsor: Boomerang Medical

Conditions Inflammatory Bowel Diseases Ulcerative Colitis
Interventions Neuromodulation
Updated 6 times since 2024 Last updated: Jul 1, 2025 Started: Jan 31, 2025 Primary completion: Feb 28, 2026 Completion: Oct 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Inflammatory Bowel Diseases and Ulcerative Colitis, this trial is actively recruiting participants. The trial is conducted by Boomerang Medical and has accumulated 6 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotNot Yet Recruiting~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – ~Aug 2025 · 5 months · monthly snapshotNot Yet Recruiting~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting NA

  2. Aug 2025 — Sep 2025 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  3. Mar 2025 — Aug 2025 [monthly]

    Not Yet Recruiting NA

  4. Feb 2025 — Mar 2025 [monthly]

    Not Yet Recruiting NA

  5. Jan 2025 — Feb 2025 [monthly]

    Not Yet Recruiting NA

▶ Show 1 earlier version

  1. Sep 2024 — Jan 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boomerang Medical
Data source: Boomerang Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations